PTC Therapeutics Competitors and Similar CompaniesClear all
PTC Therapeutics's competitors and similar companies include Lannett, ReCode Therapeutics, Ipsen and Vertex Pharmaceuticals.
 PTC Therapeutics PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs. |  ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. |  Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. | |||
Founding Date | Founding Date 1998 | Founding Date 1942 | Founding Date 2015 | Founding Date 1929 | Founding Date 1989 |
Type | Type Public | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations South Plainfield, US HQ | Locations Trevose, US HQ Philadelphia, US Seymour, US | Locations Menlo Park, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | |
Employees | Employees 75448% increase | Employees 484 | Employees 1062% decrease | Employees 5,358 | Employees 5,40013% increase |
Valuation ($) | Valuation ($) 3.3 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 10.2 b | Valuation ($) 121.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.7b (FY, 2025) | Revenue (est.) $340.6m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $12b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $294.5m (FY, 2022) | Cost of goods N/A | Cost of goods €659.1m (FY, 2025) | Cost of goods $1.7b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $33.2m (FY, 2022) | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit $10.4b (FY, 2025) |
Net income | Net income $682.6m (FY, 2025) | Net income ($231.6m) (FY, 2022) | Net income N/A | Net income €445.1m (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 28m | Total funding raised $ 82m | Total funding raised N/A | Total funding raised $ 2.4m |
For sources of this data, please see the company profile
View Company Profiles
Lannett
HQ
Trevose, US
Lannett is a company that specializes in pharmaceutical product families.
View companyReCode Therapeutics
HQ
Menlo Park, US
Employees
106↓ 2% decrease
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View companyVertex Pharmaceuticals
HQ
Boston, US
Employees
5,400↑ 13% increase
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
View company